Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 2

Abstract

Introduction: Thalassaemia Major patients require frequent blood transfusion leading to iron overload. Excessive iron gets deposited in vital organs and leads to dysfunction of the heart, liver, anterior pituitary, pancreas, and joints. Our body has limited mechanism to excrete iron, so patients with iron overload and its complications need safe and effective iron chelation therapy. Aim: To assess the efficacy of Deferasirox (DFX) as an iron chelator, with specific reference to reduction in serum ferritin level. Materials and Methods: This is a prospective; observational study done in 45 multitransfused Thalassaemia Major Children receiving DFX therapy at registered Thalassaemia society Raipur Chhattisgarh. DFX was given in an initial dose of 20 mg/kg/day and according to response increased to a maximum of 40 mg/kg/ day. Serum ferritin level was estimated at time of registration and at every three monthly intervals (four times during study period). The primary end point of the study was change in serum ferritin level after 12 months of DFX therapy. Results: The mean serum ferritin before DFX therapy of all cases was 3727.02 ng/mL. After 12 months of mean dose of 38 mg/kg/ day of DFX, the mean decline in serum ferritin was 1207.11 ng/ mL (drop by 32.38%, p-value <0.001). Conclusion: DFX monotherapy has a good safety profile and effectively chelates total body iron in Thalassaemia major patients.

Authors and Affiliations

Shikha Jaiswal, Rajesh Hishikar, Onkar Khandwal, Manju Agarwal, Usha Joshi, Ajay Halwai, Basant Maheshwari, Raka Sheohare

Keywords

Related Articles

Aortopulmonary Window: Case Report of Survival in Untreated Adult Patient

ABSTRACT Aortopulmonary window is a rare congenital communication between ascending aorta and main pulmonary artery. The condition carries poor prognosis in absence of early corrective surgery. Few case reports exist in...

Analgesic Effect of Intra-articular Morphine or Dexmedetomidine Added with Levobupivacaine in Arthroscopic Knee Surgeries - A Comparative Evaluation

Introduction: Knee arthroscopy is associated with variable amount of postoperative pain. In an attempt to improve postoperative analgesia, intra-articular injection of local anaesthetic in combination with other agent ha...

Effect of Yoga on Nonlinear Dynamics of Heart Rate in Prediabetic Subjects

ABSTRACT Introduction: Pre-diabetes represents the initial stage of type 2 diabetic disease developments. Prediabetes disease progression to overt type 2 diabetes occurs when pancreatic beta cells cannot produce insulin...

EBUS- TBNA-Initial Experience from a Tertiary Care Center in Southern India

ABSTRACT Introduction: Conventional trans bronchial needle aspiration is associated with a low diagnostic yield in mediastinal adenopathy. Ultra sound guidance improves the diagnostic yield in these cases. Though linear...

Effect of Falcaria vulgaris against Toxic Effect of Ethanol to the Rat’s Liver

ABSTRACT Introduction: Alcoholic liver disease is the most important side effect of alcohol consumption. Falcaria vulgaris (F. vulgaris) plant or long leaf contains antioxidant and antimicrobial ingredients. This plant i...

Download PDF file
  • EP ID EP332147
  • DOI 10.7860/JCDR/2017/22650.9395
  • Views 130
  • Downloads 0

How To Cite

Shikha Jaiswal, Rajesh Hishikar, Onkar Khandwal, Manju Agarwal, Usha Joshi, Ajay Halwai, Basant Maheshwari, Raka Sheohare (2017). Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients. Journal of Clinical and Diagnostic Research, 11(2), 1-3. https://www.europub.co.uk/articles/-A-332147